中国生物工程杂志

［1］ Hill C S. Molecular diagnostic testing for infectious diseases using TMA technology. Exp Rev Mol Diagn, 2001, 1(4): 445455. 
［2］ Nelson N C, Kacian D L, Chemiluminescent DNA probes: a comparison of the acridinium ester and dioxetane detection systems and their use in clinical diagnostic assays. Clin Chem Acta, 1990, 194(1): 7390. 
［3］ Nelson N C. Simultaneous detection of multiple nucleic acid targets in a homogeneous format. Biochemistry, 1996, 35(25): 84298438. 
［4］ Roth W K, Seifried E. Yield and future issues of nucleic acid testing. Transfus Clin Biol, 2001, 8(3): 282284. 
［5］ Shankarkumar U. The human leukocyte antigen (HLA) system. Int J Hum Genet, 2004, 4(2): 91103. 
［6］ Takato O Y, Matsubara K, Akira K, et al. HLADRB1, DQB1, DPB1 alleles of hemophilia brothers treated with coagulation factors contained HIV1 in Japan. Human Immunology, 1996, 47(12): 120. 
［7］ Wu L C, Matsubara K, Kobayashi A, et al. HLADRB1, DQB1, DPB1 alleles of the Orochi population in Heilong Jian Province, China.Human Immunology, 1996, 47(12): 60. 
［8］ Loiseau P, Lepage V, Séité V, et al. Clinical evaluation of a HLADRB typing method using acridiniumesterlabeled probes. Human Immunology, 1996, 47(12):46. 
［9］ Anajane S, Koichi M, Eric M, et al. A comparative study of HLADRB typing by TMA/HPA versus PCR/SSOP. Human Immunology, 1996, 47(12): 43. 
［10］ Smith A G, Matsubara K, Mickelson E, et al. A comparative study of HLADRB typing by transcriptionmediated amplification with the hybridization protection assay (TMA/HPA) versus PCR/SSOP. Human Immunology, 1997, 55(1): 7484. 
［11］ Schweitzer B, Kingsmore S. Combining nucleic acid amplification and detection. Curr Opin Biotechnol, 2001, 12(1):2127. 
［12］ Jonas V, Hill C S. Use of the Genprobe transcription mediated amplification system for the direct detection of Mycobacterium tuberculosis in clinical specimens. Tubercle and Lung Disease, 1995, 76 (2): 1415. 
［13］ John S B, Gbo Y, Geoffrey F, et al. Clinical evaluation of the enhanced GenProbe amplified Mycobacterium tuberculosis direct test for rapid diagnosis of tuberculosis in prison inmates. J Clin Microbiol, 1999, 37(5) 14191425. 
［14］ Limberger R J, Biega R, Evancoe A, et al. Evaluation of culture and the GenProbe PACE 2 assay for detection of Neisseria gonorrhoeae and Chlamydia trachomatis in endocervical specimens transported to a state health laboratory. J Clin Microbiol, 1992, 30(5):11621166. 
［15］ Warren R, Dwyer B, Plackett M, Comparative evaluation of detection assays for Chlamydia trachomatis. J Clin Microbiol, 1993, 31(6): 16631666. 
［16］ Hale Y M, Melton M E, Lewis J S, et al. Evaluation of the PACE 2 Neisseria gonorrhoeae assay by three public health laboratories. J Clin Microbiol, 1993, 31(2): 451453. 
［17］ Iwen P C, Walker R A, Warren K L, et al. Evaluation of nucleic acidbased test (PACE 2C) for simultaneous detection of Chlamydia trachomatis and Neisseria gonorrhoeae in endocervical specimens. J Clin Microbiol, 1995, 33(10):25872591. 
［18］ Mine H, Emura H, Miyamoto M. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. J Virol Methods, 2003, 112(12): 145151. 
［19］ 吴剑媚, 张庆武. 核酸检测技术在血液病毒筛查中的应用及风险评估.临床输血与检验, 2008, 10(1): 8690. Wu J M，Zhang Q W. J Clin Transfus Lab Med, 2008, 10(1): 8690. 
［20］ Nasreen K, Sali A, Hamid S, et al. Improved detection of HCV infection in hemodialysis patients using a new HCV RNA qualitative assay: experience of a transplant center. J Clin Virol, 2004(2):175182. 
［21］ Lorraine C, Frank A, Marc G, et al. Transcriptionmediated amplification is more sensitive than conventional PCRbased assays for detecting residual serum HCV RNA at end of treatment.The American Journal of Gastroenterology, 2001, 96(10): 29682972. 
［22］ Hofmann W P, Dries V, Herrmann E, et al. Comparison of transcription mediated amplification (TMA) and reverse transcription polymerase chain reaction (RTPCR) for detection of hepatitis C virus RNA in liver tissue. J Clin Virol, 2005, 32(4): 289293. 
［23］ Lorraine C, Claudia E, Kimmy L, et al. Successful HCV genotyping of previously failed and low viral load specimens using an HCV RNA qualitative assay based on transcriptionmediated amplification in conjunction with the line probe assay. J Clin Virol, 2003, 28(1): 1426. 
［24］ Nicola M Z, Ann M, Sally L, et al. Performance of a transcriptionmediated amplification HIV1 RNA assay in pooled specimens. J Clin Virol, 2007, 40(1): 6870. 
［25］ Tatsuya I, Ryukichi K, Teruko H, et al. Transcriptionmediated amplification is more useful in the followup of patients with chronic hepatitis B treated with lamivudine. Hepato Res, 2001, 21(1): 7684. 
［26］ Giachetti C, Linnen J M, Kolk D P, et al. High throughput multiplex assay for sensitive detection of HIV1 and HCV RNA. J Clin Microbiol, 2002, 40(7):24082419. 
［27］ Jeffrey M L, Gilker M J, Alanna M, et al. Sensitive detection of genetic variants of HIV1 and HCV with an HIV1/HCV assay based on transcriptionmediated amplification. J Virol Methods, 2002, 102(12): 139155. 
［28］ McCormick M K, Dockter J, Linnen J M, et al. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA. J Clin Virol, 2006, 36(3): 166176.